Related Experiment Video
Updated: Jun 19, 2026

12:27
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
AGGLUTINATION PHENOMENA IN LOBAR PNEUMONIA
1Hospital of The Rockefeller Institute for Medical Research.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Agglutinins in lobar pneumonia patients indicate infection by specific pneumococci groups. Their absence in severe cases may signal a poor prognosis, while Pneumococcus mucosus infections show no agglutinins.
Area of Science:
- Bacteriology
- Immunology
- Clinical Medicine
Background:
- Lobar pneumonia is a significant bacterial infection.
- Pneumococci are a common cause of bacterial pneumonia.
- Understanding immune responses in pneumonia is crucial for diagnosis and prognosis.
Purpose of the Study:
- To investigate the presence and significance of agglutinins in patients with lobar pneumonia.
- To determine the correlation between agglutinin presence and the type of pneumococcus involved.
- To assess the prognostic value of agglutinins in severe and fatal pneumonia cases.
Main Methods:
- Serological testing for agglutinins in patient blood samples.
- Categorization of pneumococci into serological groups (I, II, III, and IV).
- Correlation of agglutinin detection with disease severity, outcome, and causative pneumococcal type.
Main Results:
- Agglutinins were detected in 73.8% of lobar pneumonia cases caused by pneumococci groups I, II, and IV.
- Absence of agglutinins in severe/fatal cases suggests unfavorable prognostic significance.
- No agglutinins were demonstrable in infections caused by Pneumococcus mucosus (group III).
- Agglutinins appeared around the crisis, varied in duration, and showed type-specific reactions, particularly for groups I, II, and IV.
Conclusions:
- Agglutinins are valuable diagnostic markers in specific pneumococcal pneumonia types.
- The absence of agglutinins in severe cases warrants further investigation for prognostic indicators.
- Agglutinin specificity aids in differentiating pneumococcal types and understanding host immune response.
Related Concept Videos
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
